Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Bayer, a leading healthcare product manufacturer, said today it will invest up to 100 million euros ($129.22 million) in the coming five years to establish a research and development (R&D) center in
The need for German pharmaceutical company Bayer to restructure is discussed almost daily in the press. In these reports, the name of one blockbuster always comes up: Xarelto. Its substance patent
Bayer AG, one of the top five hundred enterprises in the world, attaches great importance to its IPR development. In 2009, a small private enterprise in Henan province (China) tried to establish
Recently, Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc. filed a complaint in the Northern District of West Virginia against Mylan Pharmaceuticals Inc. and Mylan Inc. alleging patent
For years, Bayer has fought a fierce pan-European battle over its cancer drug Nexavar. The dispute concerns Bayer’s patent EP 2 305 255, which expired in December 2022. The patent protects the
total 1 pages, 5 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
